ITI2020-10-012020-12-31in-bse-fin:OneOperatingExpenses01Member ITI2020-10-012020-12-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ITI 2020-04-01 2021-03-31 2021-02-04 INR Lakhs Third quarter Single segment The Company is primarily engaged in business of manufacturing, trading and servicing of telecommunication equipments and rendering other associated / ancillary services and there are no other reportable segments. The Company is primarily operating in India, which is considered as a single geographical segment. The company is also engaged in Defence projects. 2020-10-01 2020-12-31 Unaudited Standalone 4968800000.00 101600000.00 5070400000.00 4216800000.00 241700000.00 -214300000.00 503600000.00 405000000.00 108300000.00 126900000.00 5388000000.00 -317600000.00 0.00 -317600000.00 0.00 0.00 0.00 0.00 -317600000.00 0.00 0.00 0.00 0.00 -317600000.00 9800000.00 -307800000.00 0.00 0.00 9251200000.00 10 -0.34 -0.34 0.00 0.00 -0.34 -0.34 0.00 0.00 0.00 1.tThe above financial results for the period ended 31.12.2020 were reviewed by the Audit Committee on 12.02.2021 and upon its recommendations, were approved by the Board of Directors at their meeting held on 12.02.2021 n2.tThese results have been prepared in accordance with the IND AS notified under the companies (Indian Accounting Standards) Rules 2015, as amended. n3.tA Limited Review of the above Unaudited Financial Results has been carried out by Statutory Auditors of the Company pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulations,2015. n4.tThe Company is primarily engaged in business of manufacturing, trading and servicing of telecommunication equipments and rendering other associated / ancillary services and there are no other reportable segments. The Company is primarily operating in India, which is considered as a single geographical segment. The company is also engaged in Defence projects. The MCA vide its notification dt.23.02.2018 has exempted companies engaged in the Defence production from the requirement of Segment Reporting. n5.tThe Company is a Sick Company as per provisions of Sick Industrial Companies Act(SICA), 1985. CCEA has approved a financial assistance of Rs 4156.79 crore in February, 2014, for revival of ITI under Rehabilitation Scheme. n6.tThe company has estimated from internal sources that there is a decrease in turnover due to COVID-19. The recent Pandemic outbreak (COVID-19) has brought about economic disruptions and uncertainties and ascertaining its impact is difficult. The Company has considered the possible material events and circumstances arising from COVID-19 up to the date of approval of the financial results and their impact on the carrying value of its Assets & Liabilities as at 31st December 2020. Based on its evaluation, the company expects to recover the carrying amount of its Assets as on 31st December 2020. The impact of any future events & developments emerging out of COVID-19 Pandemic, if any, and occurring after the approval of financial result for the quarter and relating to the Assets & liabilities of the Company as on 31st December 2020 will be recognized prospectively. n7.tThe company has received Rs 15500 lakhs towards VRS expenditure. Up to the beginning of FY 2020-21 Rs 4097.51 lakhs was spent. During the 1st half of the year 2020-21 the company has incurred Rs 6646.64 lakhs towards VRS expenses and the same has been appropriated from the Grants. As on 30th September 2020 balance un spent Grant remained at Rs 4755.85 lakhs. n8.tThe above results are available at www.itiltd.in and website of stock exchanges at www.bseindia.com and nseindia.com. Single segment 2020-04-01 2020-12-31 Unaudited Standalone 10958600000.00 966400000.00 11925000000.00 8252900000.00 1427500000.00 -383200000.00 2186100000.00 1259700000.00 328000000.00 754900000.00 13825900000.00 -1900900000.00 0.00 -1900900000.00 0.00 0.00 0.00 0.00 -1900900000.00 0.00 0.00 0.00 0.00 -1900900000.00 29400000.00 -1871500000.00 0.00 0.00 9251200000.00 10 -2.05 -2.05 0.00 0.00 -2.05 -2.05 0.00 0.00 0.00 Other Expenses 126900000.00 Other Expenses 754900000.00